COPD is one of the most common lung conditions in the country. If you experience shortness of breath, wheezing or difficulty ...

In spite of the fact that chronic circulatory and respiratory conditions engender a significant amount of suffering [1] and cause more deaths among older adults in developed countries than cancer, ...

Brensocatib, a DPP1 inhibitor, is the first FDA-approved therapy for non-cystic fibrosis bronchiectasis, showing significant clinical and structural benefits. The ASPEN trial demonstrated that ...

A tool combining CV risk score (CVRS) and coronary artery calcium score (CACS) facilitates stratification of patients with COPD at risk for MACE.

Research on Chronic Obstructive Pulmonary Disease (COPD) requires further examination of rural health disparities and the impact of sociocultural and environmental exposures on health outcomes, ...

COPD research needs to increase focus on rural health disparities and consider the impact of sociocultural and environmental ...

Please provide your email address to receive an email when new articles are posted on . Text messages addressing barriers to preventer inhaler use came from general practitioner practices. Patients ...

Temple Health leads research showing how women and non-smokers face rising risks, and how new treatments are changing the ...

COPD is a group of lung diseases that get worse over time. It prevents airflow to the lungs, causing breathing problems and ...